Future of Specialty Pharmacy Highlights SPT Week in Review
Top articles of the week from Specialty Pharmacy Times.
CT-P10 is indicated to treat a form of non-Hodgkin lymphoma and rheumatoid arthritis.
New analysis examines opioid use among patients with rheumatoid arthritis.
The CEO of the Cutaneous Lymphoma Foundation describes the challenges of living with the disease.
An estimated 200 orphan drug designation requests are pending FDA review.